Inferior cancer survival for men with localized high-grade prostate cancer but low prostate-specific antigen
Authors
Fankhauser, Christian DGonzalez-Feliciano, A. G.
Clarke, Noel W
Hermanns, T.
Stopsack, K. H.
Fiorentino, M.
Loda, M.
Mahal, B.
Gerke, T. A.
Preston, M. A.
Mucci, L. A.
Penney, KL
Affiliation
Department of Urology, University Hospital Zurich, University of Zurich, Zurich, Switzerland;Issue Date
2020
Metadata
Show full item recordAbstract
NoneCitation
Fankhauser CD, Penney KL, Gonzalez-Feliciano AG, Clarke NW, Hermanns T, Stopsack KH, et al. Inferior Cancer Survival for Men with Localized High-grade Prostate Cancer but Low Prostate-specific Antigen. Eur Urol. 2020.Journal
European UrologyDOI
10.1016/j.eururo.2020.05.035PubMed ID
32624279Additional Links
https://dx.doi.org/10.1016/j.eururo.2020.05.035Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.eururo.2020.05.035
Scopus Count
Collections
Related articles
- The Long-Term Risks of Metastases in Men on Active Surveillance for Early Stage Prostate Cancer.
- Authors: Maggi M, Cowan JE, Fasulo V, Washington SL 3rd, Lonergan PE, Sciarra A, Nguyen HG, Carroll PR
- Issue date: 2020 Dec
- Initial management of prostate-specific antigen-detected, low-risk prostate cancer and the risk of death from prostate cancer.
- Authors: Aizer AA, Chen MH, Hattangadi J, D'Amico AV
- Issue date: 2014 Jan
- Ongoing Gleason grade migration in localized prostate cancer and implications for use of active surveillance.
- Authors: Weiner AB, Etzioni R, Eggener SE
- Issue date: 2014 Oct
- Prostate cancer: primary ADT monotherapy not suitable for localized disease.
- Authors: Sartor O, Silberstein J
- Issue date: 2014 Jun
- Men presenting with prostate-specific antigen (PSA) values of over 100 ng/mL.
- Authors: Ang M, Rajcic B, Foreman D, Moretti K, O'Callaghan ME
- Issue date: 2016 Apr